Locus Cell Co., Ltd. (TPEX:6891)
Taiwan · Delayed Price · Currency is TWD 28.85
+0.05 (0.17%)
At close: Dec 19, 2025
Locus Cell Market Cap
Locus Cell has a market cap or net worth of 5.77 billion as of December 19, 2025. Its market cap has increased by 27.65% in one year.
Market Cap
5.77B
Enterprise Value
5.02B
Revenue
5.18M
Ranking
n/a
PE Ratio
n/a
Stock Price
28.85
Market Cap Chart
Since April 28, 2022, Locus Cell's market cap has decreased from 9.88B to 5.77B, a decrease of -41.60%. That is a compound annual growth rate of -13.71%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 19, 2025 | 5.77B | 44.61% |
| Dec 31, 2024 | 3.99B | -36.67% |
| Dec 29, 2023 | 6.30B | -12.86% |
| Dec 30, 2022 | 7.23B | -26.82% |
| Apr 28, 2022 | 9.88B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 234.19B |
| PharmaEssentia | 183.26B |
| Heron Neutron Medical | 82.78B |
| Lotus Pharmaceutical | 74.16B |
| Bora Pharmaceuticals Co., LTD. | 60.97B |
| Lin BioScience | 33.26B |
| Lumosa Therapeutics | 31.33B |
| Center Laboratories | 28.22B |